Follistatin antagonists are disclosed. The antagonists are polypeptides that include a non-activin-binding FS N-Domain or non-activin-binding FLRG N-Domain; and a heparin sulfate-binding moiety; wherein the tryptophan residue (W) at position 4 or 36 of the non-activin-binding N-Domain is substituted by a non-aromatic amino acid such as alamine. An example of a heparin sulfate-binding moiety is Domains I-III of human follistatin.
申请公布号
WO0109368(A1)
申请公布日期
2001.02.08
申请号
WO2000US20444
申请日期
2000.07.27
申请人
THE GENERAL HOSPITAL CORPORATION;KEUTMANN, HENRY, T.;SCHNEYER, ALAN;SIDIS, YISRAEL;SLUSS, PATRICK
发明人
KEUTMANN, HENRY, T.;SCHNEYER, ALAN;SIDIS, YISRAEL;SLUSS, PATRICK